Neurocrine Biosciences · 3 weeks ago
Sales Training Intern
San Diego, CA
Internship
Onsite
InternNeurocrine Biosciences is a leading neuroscience-focused biopharmaceutical company dedicated to discovering and developing life-changing treatments. The Sales Training Intern will gain valuable experience in sales, marketing, and leadership within the biotechnology field, supporting various activities and collaborating with cross-functional teams.
BiotechnologyHealth CarePharmaceutical
Responsibilities
Supporting a range of activities, including: Sales Meetings, New Hire Classes, and day to day activities within the sales training department
Possibly attending a sales meeting, either locally or in a different city
Collaborating with a cross functional team and completing various sales and sales training related projects
Completing a CORE Strengths Assessment and presenting your learnings to the Sales Training Team
Scheduling several 30-minute informational interviews with key members of the Commercial Leadership Team
A minimum of one field ride shadowing a field-based Account Specialist
Interacting with various areas within the company including sales, clinical, market access, marketing etc
Collaborating with a mentor team of cross-functional team members as well as the other interns in the class
Completing a special project and presenting it to the Sales Training and Leadership Development Teams
Qualification
Required
Pursuing an undergraduate degree with an interest in biotechnology; specifically, sales and/or marketing
Specific degree or field required: Business, Communications, Marketing, or a related degree
A strong interest in sales and/or marketing
Good verbal and written communication skills
Ability to think creatively and be a team player
Commitment to a 10-week internship
Preferred
Video production, editing and social media skills preferred
Prior experience in the pharmaceutical or biotechnology industry would be an asset but is not required
Company
Neurocrine Biosciences
Neurocrine Biosciences engages in the discovery and development of drugs for the treatment of neurological and endocrine-related diseases.
Founded in 1992
1001-5000 employees
Funding
Current Stage
Public CompanyTotal Funding
$260MKey Investors
Venrock
2015-02-19Post Ipo Equity· $250M
2009-12-17Post Ipo Equity· $10M
1996-05-31IPO
Leadership Team
Matt Abernethy
Chief Financial Officer
D
Dimitri Grigoriadis
VP, Research
Recent News
2026-01-06
Company data provided by crunchbase